요로감염 소아에서 혈청 Cystatin C 측정의 임상적 적용 = Correlation between Serum Cystatin C Levels and Clinical Parameters in Children with Urinary Tract Infections

다국어 초록 (Multilingual Abstract)

Purpose: We aimed to investigate the correlation between serum cystatin C and clinical manifestations in pediatric patients with urinary tract infections (UTIs). Methods: We studied 137 patients admitted with UTIs from June 2012 to May 2014. Depending on the presence of renal cortical defects on 99m Tc-dimercaptosuccinic acid scintigraphy, we classified patients into non-renal and renal defect groups. Laboratory and clinical parameters were analyzed, including the levels of serum cystatin C. The correlation between cystatin C and other variables was assessed. Results: Serum cystatin C levels did not differ between the non-renal and renal defect groups. In both groups, serum cystatin C levels increased after 4-5 days of treatment, compared with the level at admission (P<0.001). However, mean levels were within normal ranges. The concentration of serum cystatin C positively correlated with serum creatinine and negatively correlated with age (P <0.05). In contrast, there was no correlation between serum cystatin C and other variables. Conclusion: Serum cystatin C does not appear to be a useful biomarker for renal defects in pediatric patients with UTIs. Further studies are necessary to conclude whether serum cystatin C is helpful in predicting deterioration in renal function in pediatric patients with UTIs.

참고문헌 (Reference)

1 Nejat M, "Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit" 14 : 85-, 2010

2 Jakobsson B, "Transient pyelonephritic changes on 99mTechnetium-dimercaptosuccinic acid scan for at least five months after infection" 86 : 803-807, 1997

3 Newman TB, "The new American Academy of Pediatrics urinary tract infection guideline" 128 : 572-575, 2011

4 Cho SY, "The clinical significance of serum cystatin C in critically ill newborns with normal serum creatinine" 26 : 267-271, 2012

5 Kyhse-Andersen J, "Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate" 40 : 1921-1926, 1994

6 Dharnidharka VR, "Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis" 40 : 221-226, 2002

7 Wiesli P, "Serum cystatin C is sensitive to small changes in thyroid function" 338 : 87-90, 2003

8 Krawczeski CD, "Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass" 5 : 1552-1557, 2010

9 Ristikankare A, "Serum cystatin C in elderly cardiac surgery patients" 89 : 689-694, 2010

10 Coll E, "Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment" 36 : 29-34, 2000

11 Grubb A, "Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate" 218 : 499-503, 1985

12 Vinge E, "Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults" 59 : 587-592, 1999

13 Smolkin V, "Procalcitonin as a marker of acute pyelonephritis in infants and children" 17 : 409-412, 2002

14 Shaikh N, "Prevalence of urinary tract infection in childhood: a meta-analysis" 27 : 302-308, 2008

15 Yim HE, "Predictive value of urinary and serum biomarkers in young children with febrile urinary tract infections" 29 : 2181-2189, 2014

16 "Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection" 103 (103): 843-852, 1999

17 Bolignano D, "Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage" 52 : 595-605, 2008

18 Yiee J, "Management of fetal hydronephrosis" 23 : 347-353, 2008

19 Martensson J, "Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients" 27 : 576-581, 2012

20 Knight EL, "Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement" 65 : 1416-1421, 2004

21 Saleh Y, "Expression of cystatin C in clinical human colorectal cancer tissues" 5 : 49-53, 2005

22 Tokyol C, "Expression of cathepsin D in bladder carcinoma:correlation with pathological features and serum cystatin C levels" 92 : 230-235, 2006

23 Ahlstrom A, "Evolution and predictive power of serum cystatin C in acute renal failure" 62 : 344-350, 2004

24 Gerbes AL, "Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver" 50 : 106-110, 2002

25 Winberg J, "Epidemiology of symptomatic urinary tract infection in childhood" 1-20, 1974

26 Risch L, "Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients" 47 : 2055-2059, 2001

27 Herget-Rosenthal S, "Early detection of acute renal failure by serum cystatin C" 66 : 1115-1122, 2004

28 Stokland E, "Early 99mTc dimercaptosuccinic acid (DMSA) scintigraphy in symptomatic first-time urinary tract infection" 85 : 430-436, 1996

29 Jacobson SH, "Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up" 299 : 703-706, 1989

30 Armangil D, "Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants" 23 : 2081-2083, 2008

31 Herget-Rosenthal S, "Cystatin C: efficacy as screening test for reduced glomerular filtration rate" 20 : 97-102, 2000

32 Bokenkamp A, "Cystatin C--a new marker of glomerular filtration rate in children independent of age and height" 101 : 875-881, 1998

33 Randers E, "Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels" 61 : 333-335, 2001

34 Ylinen EA, "Cystatin C as a marker for glomerular filtration rate in pediatric patients" 13 : 506-509, 1999

35 Morgan MG, "Controversies in the laboratory diagnosis of community-acquired urinary tract infection" 12 : 491-504, 1993

36 Jaye DL, "Clinical applications of C-reactive protein in pediatrics" 16 : 735-746, 1997

37 Majd M, "Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model" 218 : 101-108, 2001